“…(4) This is especially so for fusiform aneurysms that have lower complication rates. (5) Thrombolytic therapy with recombinant tissue plasminogen activator was deemed to be harmful in one case, in which mobilisation of the thrombus in the SVC aneurysm resulted in recurrent pulmonary embolism. (3) Surgical resection, usually through a median sternotomy approach, has been advocated for saccular aneurysms due to risks of complications, (1) and for aneurysms that are larger than 40 mm, growing or symptomatic, or those that contain thrombi.…”